|Articles|October 25, 2016
Cogstate, Clinical Ink Collaborate to Deliver CNS eCOA
Cogstate Ltd., a cognitive science company, and Clinical Ink, a provider of eSource and patient engagement technologies, have announced an alliance.
Advertisement
Cogstate Ltd., a cognitive science company, and Clinical Ink, a provider of eSource and patient engagement technologies, have announced an alliance. This collaboration will provide a tablet based eCOA solution for CNS clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
3
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
4
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
